跳至主要内容
临床试验/NCT02853422
NCT02853422已完成不适用

A Study Evaluating The Clinical Utility Of The Health-Related Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours QUALINETS Study

Ipsen32 个研究点 分布在 2 个国家目标入组 199 人开始时间: 2016年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Ipsen
入组人数
199
试验地点
32
主要终点
Survey on the clinical utility of the QLQ-GINET21, which the investigator is to complete for each patient enrolled

研究概览

简要总结

The purpose of this study is to evaluate the utility of the QLQ-GINET21 in making clinical and therapeutic decisions.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with a diagnosis of gastrointestinal endocrine tumour.
  • Patient able to read and understand the study questionnaires.
  • Patient who has given informed consent in writing to take part in the study.

排除标准

  • Patient who is taking part in another clinical study during the study.
  • Patients with another serious malignancy.
  • Patients unable to meet the requirements of the protocol (non-compliant patients or those unfit to answer the questionnaires).

结局指标

主要结局

Survey on the clinical utility of the QLQ-GINET21, which the investigator is to complete for each patient enrolled

时间窗: Day 1

次要结局

  • Socio-demographic variables of the investigator(Day 1)
  • Socio-demographic variables of the patient(Day 1)
  • Patients' health-related quality of life concerning gastrointestinal neuroendocrine using QLQ-GINET21(Day 1)
  • Health status as perceived by the patient(Day 1)
  • Patients' health-related quality of life concerning gastrointestinal neuroendocrine using QLQ-C30(Day 1)
  • Clinical assessment of patient's health status by the investigator(Day 1)
  • Clinical characteristics of patients - time since first therapeutic intervention(Day 1)

研究者

发起方
Ipsen
申办方类型
Industry
责任方
Sponsor

研究点 (32)

Loading locations...

相似试验

Quality-Of-Life QLQ-GINET21 Questionnaire In The... | 临床试验